|Articles|June 21, 2013
TransCelerate's Risk Based Monitoring Goes on Tour
Author(s)Lisa Henderson
Next week at DIA, two of TransCelerate?s Risk Based Monitoring workstream members will take their newly released methodology to the people.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5